Together. INFINITE POSSIBILITIES.

Similar documents
XIENCE Sierra INTRODUCING

12:00-13:00 Training room GE Healthcare-Boston Scientific Training Village Interventions for Valvular Disease TAVI Focus on Imaging

Biosensors Technology at Euro PCR 2016

See the key highlights of Boston Scientific at EuroPCR2016:

CARDIOLOGY NEWSLETTER

BALLROOM C BALLROOM B SENTRAL BALLROOM Emcee : Chairpersons: Panelists: Updates on MySTEMI Network towards an Ideal STEMI network

4:30 p.m. Jack Vogel Memorial Lecture Evolution and Revolution in the Treatment of Valvular Heart Disease Dr. Mack

InTouch. InTouch Cardiology Newsletter. Congresses and Events. Educational Corner. Clinical Studies. Issue 2

Joint Congress PAFCIC Complex PCI meeting

Modern aspects in multidisciplinary thromboembolic prophylaxis. AMPLATZER Left Atrial Appendage data update

Hands on workshops. 08:00-10:15 Session 1 - LAA morphology and imaging Moderator: Saibal Kar, MD / Shakeel A. Qureshi, MD / Bushra Rana, MD

3 rd BELGIAN LEFT ATRIAL APPENDAGE OCCLUSION MEETING. Friday Hotel Dolce La Hulpe Brussels

AMPLATZER Amulet Left Atrial Appendage Occluder

Scientific Program of LAA 2014

PressureWire Aeris with Agile Tip Technology. Wireless FFR Functionality and Handles like a Workhorse PCI Guidewire 1

Emerging Cardiac Technologies. Thomas D. Conley, MD FACC FSCAI BHHI Primary Care Symposium February 27, 2015

CoreValve High Risk Study - Neu

INDUSTRY PROSPECTUS. EACTS Course in Cardiovascular Innovation. 10th International Leipzig-Dallas Meeting

POSTGRADUATE COURSE IN HEART FAILURE A NOVEL COURSE IN HEART FAILURE MANAGEMENT

Preparing for Your Transcatheter Mitral Valve Repair Procedure

The tailored solution for your bifurcation therapy

Young cardiologists share their knowledge to improve patient outcomes

EUROPCR ANNUAL CONGRESS 2016

UNDERSTANDING TREATMENT OPTIONS FOR HEART DISEASE. Visit

APPLICATION FOR INTERVENTIONAL STRUCTURAL HEART DISEASE CARDIOLOGY FELLOWSHIP

MEDTRONIC SCIENTIFIC PROGRAM

Update interventional Cardiology Hans Rickli St.Gallen

Tuesday, October 23, 2018

Transcatheter aortic valve implantation for severe aortic valve stenosis with the ACURATE neo2 valve system: 30-day safety and performance outcomes

ACCESS-EUROPE Phase I

PERCUTANEOUS STRUCTURAL UPDATES TAVR WATCHMAN(LEFT ATRIAL APPENDAGE OCCLUDERS) MITRACLIP PARAVALVULAR LEAK REPAIRS ASD/PFO CLOSURES VALVULOPLASTIES

Scientific Program of CSI Focus Imaging 2017

The SAPIEN 3 TAVI Advantage

Establishing a New Path Forward for Patients With Severe Symptomatic Aortic Stenosis THE PARTNER TRIAL CLINICAL RESULTS

The jailed side branch and OCT guided cross over. Accidental abluminal rewiring, OCT check or optimal technique?

Edwards' solution for patients suffering from tricuspid valve disease

BRING LIVING BACK TO LIFE. An Educational Booklet for Recipients of the Abbott Portico Transcatheter Aortic Valve

Tailored bifurcation therapy

RANDOMISED TRIALS TAVI WITH SAVR STEPHAN WINDECKER AORTIC VALVE DISEASE COMPARING

ADVANCED TAVI IMAGING

PressureWire Agile Tip Technology

Tuesday, October 23, 2018

ACT Program. Left Main Intensive Course FFR & IVUS Guided PCI CTO LIVE from the Experts TAVI Session. Organizing Director

EDUCATION PROGRAM. Jagiellonian University College. Al Dorrah Heart Care Hospital Cairo, Egypt. Erasmus MC ThoraxCenter Rotterdam, Netherlands

PCHF. A novel course in heart failure management POSTGRADUATE COURSE IN HEART FAILURE

Prospective, multicentre evaluation of the DESolve Novolimus-Eluting coronary BRS: imaging outcomes and 5Y clinical and imaging results

Prof. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation

Evolution In Interventional Cardiology. Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands

How to manage device embolization?

David Hildick-Smith, John Camm, Hans-Christoph Diener, Ulf Landmesser, Vincent Paul, Boris Schmidt, Magnus Settergren, Emmanuel Teiger, Claudio Tondo

Watchman. Left Atrial Appendage Closure Device. Uniquely engineered for the LAA 1-3 with proven safety and longterm efficacy. 4-8

introducing Quantien Integrated FFR Platform Free Your Cath Lab with Wireless FFR

OrbusNeich at TCT Late Breaking, Presentations and Poster Sessions

PERCUTANEOUS TRANSCATHETER CLOSURE OF PARAVALVULAR LEAK

2019 MITRACLIP CODING AND PAYMENT GUIDE

Bifurcations Have Met Their Match

VIENNA HEART M AY FAILURE ADVANCE PROGRAMME. World Congress on Acute Heart Failure. Organised by the Heart Failure Association of the ESC

FOCUS: Valve Medical University Innsbruck INNSBRUCK AUSTRIA SEPT ,

EAPCI: Biodegradable Scaffolds-Writers 2016

3 years after introduction of TAVI in QEH. Michael KY Lee On Behalf of QEH TAVI Heart Team Queen Elizabeth Hospital Hong Kong

Thessaloniki October 9, Apostolos Tzikas MD, PhD, FESC

COMPLEX CASES: LEFT MAIN

Establishing the New Standard of Care for Inoperable Aortic Stenosis THE PARTNER TRIAL COHORT B RESULTS

Non-pharmacologic Management of Structural Heart Disease

The BIO revolution: bioadsorbable stents. Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino

INPATIENT REIMBURSEMENT PROSPECTUS

Siemens Healthineers Erlangen, August 27, Siemens Healthineers presents imaging for complex, minimally invasive procedures

The VGH Interventional Cardiology Fellowship program has successfully trained 38 interventional fellows since 1993.

Standarized definition of bioprosthetic valve deterioration and failure

Peter F Ludman BCIS National Audit Lead

Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G.

Cardiology and Heart Diseases November 5-6, 2018 Amsterdam, Netherlands

Multicentre clinical study evaluating a novel resheatable self-expanding transcatheter aortic valve system

Scientific programme. Tuesday 19 th May - Friday 22 nd May

When is it too late to perform transcatheter mitral valve repair? Alec Vahanian, FESC,FRCP(Edin.) Bichat hospital University Paris VII

7 th Conference of Transcatheter Heart Valve Therapies

Indication, Timing, Assessment and Update on TAVI

Portico Transcatheter Aortic Valve Implantation System. portico PRECISION

Percutaneous Mitral Valve Repair

Current Controversies. Subclinical and clinical valve thrombosis

SYMPOSIUM III CARDIOVASCULAR DISEASE IN WOMEN

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

Isolator Synergy Ablation System THE ONLY FDA-APPROVED SURGICAL DEVICE TO TREAT ATRIAL FIBRILLATION

One-Year Outcome After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results from the TriValve Registry

30-Day Outcomes Following Implantation of a Repositionable Self-Expanding Aortic Bioprosthesis: First Report From the FORWARD Study

The Sentinel Dual Filter Device Design Features & EU Clinical Trial Results

ACVS INDIA 2017 PROGRAMME, HALL -A 18 th August 2017, HICC, HYDERABAD.

Diagnostic & Therapeutic Cardiac Catheterization Coder 2017

Educational workshop: Real-time Image-Guided HDR Brachytherapy for Prostate Cancer

Il Cuore in Fortezza Savona, 9 Aprile 2015

FANTOM II trial: Clinical results from the Fantom Sirolimus-Eluting BRS. Norbert Frey, MD University of Kiel, Germany

ABBOTT CODING GUIDE STRUCTURAL HEART AND VALVES CONGENITAL DEFECTS SURGICAL HEART VALVES AMPLATZER PFO OCCLUDER. Effective January 1, 2019

The Art of. Flow Restoration. Ikazuchi Zero. Semi-Compliant PTCA Balloon OVERVIEW CROSSABILITY LOW PROFILE CASE STUDY CODES

List of Workshops Workshop Title

MitraClip World Wide Commercial Experience

Thailand Clinical Immersion

APPLICATION FOR INTERVENTIONAL STRUCTURAL HEART DISEASE CARDIOLOGY FELLOWSHIP

Optimal Revascularization in Multivessel Disease and Coronary CTO. Dr Simon Walsh MD FRCP FSCAI Consultant Cardiologist Belfast Trust

COURSE OFFERINGS. Committed to Improving Outcomes in Cardiogenic Shock and Protected PCI Through Excellence in Education.

Thursday, December 7 th, 2017, 13:00 14:30

Transcription:

ST. JUDE MEDICAL IS NOW ABBOTT Together. INFINITE POSSIBILITIES. Abbott and St. Jude Medical have joined together. Visit us at EuroPCR 2017. Join us at our exciting scientific sessions, and explore our booth, Innovation Pavilion and Training Village.

Welcome to EUROPCR 2017 Abbott and St. Jude Medical have joined together combining our strengths, passion to achieve, and our ability to change lives, for better solutions. In this booklet you will find an overview of Abbott activities, sponsored scientific sessions and Training Village sessions that we ve organised for you at this year s EuroPCR congress. We wish you a great time at EuroPCR 2017. DISCOVER OUR LATEST TECHNOLOGIES AND MEET THE EXPERTS Join our sponsored scientific sessions and training workshops Visit our Innovation Pavilion and booth Register for dedicated sessions at our Training Village

1 6 2 2 3 4 5 4

Dedicated to helping more people ACHIEVE THEIR BEST POSSIBLE HEALTH Abbott can offer a full range of innovations, education and services to help make a difference to patients lives. Visit our booth and Innovation Pavilion 1 2 3 4 5 6 Innovation Pavilion Barista Zone Vessel Closure Structural Heart Area Lounge Area PCI Area Structural Heart Area: AMPLATZER Amulet left atrial appendage occluder MitraClip Portico Solo PCI Area: FFR wireless system Guidewires OCT Drug-eluting stents Bioresorbable scaffolds We are also offering the opportunity to unlock the potential of PCI through registration to attend our on-site, purpose-built training facility.

Join us at our SCIENTIFIC SESSIONS

Tuesday 16 th May CASE IN POINT SESSION STENTS OR SCAFFOLDS: RELEVANT OPTIONS FOR OPTIMAL PATIENT OUTCOMES? 17:15 18:45, Room: Maillot Chairpersons: D. Dudek, J. Fajadet Panellists: D. Capodanno, N.E.J. West, T. Lefevre, A.S. Petronio, A. Serra, V. Kocka A bifurcation strategy needed for my patient: stent or scaffold? T. Lefevre How would I treat this case? D. Capodanno Treatment of a young patient with long lesions: stent or scaffold? A.S. Petronio How would I treat this case? N.E.J. West A patient with a long tapered CTO lesion: stent or scaffold? A. Serra How would I treat this case? D. Capodanno My patient needs primary PCI: stent or scaffold? V. Kocka How would I treat this case? N.E.J. West TOOLS AND TECHNIQUES SESSION SELF-EXPANDING TAVI TECHNOLOGY HOW TO SAFEGUARD SIMPLICITY, SAFETY AND EFFECTIVENESS? 17:15 18:45, Room: Theatre Bordeaux Chairpersons: L. Sondergaard, S. Worthley, F. Nietlispach Panellists: S. Fichtlscherer, A. Linke, U. Schaefer, H. Moellman How to deploy the Portico valve? Step by step procedure based on expert consensus recorded case from Rigshospitalet, Copenhagen Denmark L. Sondergaard Lecture 1 S. Fichtlscherer Challenging cases in elderly patients: targeting minimal vascular complications and a low new pacemaker implantation rate recorded case from University of Leipzig, Heart Center Germany A. Linke Lecture 2 U. Schaefer

Wednesday 17 th May SYMPOSIUM STEMI AND MULTIVESSEL DISEASE: EVIDENCE ON FFR-GUIDED TREATMENT PUT INTO PRACTICE 12:30 13:30, Room: 351 Chairpersons: E. Barbato, P. Smits Panellist: P. MacCarthy STEMI patient with multivessel disease reviewing treatment options P. Smits The role of FFR in guiding treatment of non-culprit lesions in acute patients P. MacCarthy Case: implementing the available evidence in my practice E. Barbato CASE IN POINT SESSION HOW TO BEST MANAGE CONCOMITANT PROCEDURES IN STRUCTURAL HEART THERAPIES? 12:30 13:30, Room: 251 Chairpersons: F. Maisano, D. Tchétché Panellists: L. Sondergaard, D. Arzamendi How to best treat bi-valvular disease in TAVI patients; concomitant procedures or staged? L. Sondergaard Is there a future for LAA occlusion therapy in atrial fibrillation patients indicated for TAVI? D. Arzamendi SYMPOSIUM TRANSCATHETER MITRAL VALVE REPLACEMENT AND REPAIR: WHAT S THE FUTURE? 13:35 14:35, Room: 251 Chairpersons: C. Tamburino, A. Vahanian Panellists: C. Frerker, F. Maisano, S. Von Bardeleben Functional mitral regurgitation patients: when to treat with MitraClip NT? C. Frerker MitraClip NT: improving patient outcomes Case 1: S. Von Bardeleben Case 2: C. Frerker WHO are the patients to benefit from transcatheter mitral valve replacement and repair? S. Von Bardeleben The future of transcatheter mitral valve interventions F. Maisano

ABBOTT & CVPATH SPONSORED SYMPOSIUM INTRODUCTION TO POLYMER TECHNOLOGY WHAT IS RELEVANT FOR THE INTERVENTIONAL CARDIOLOGIST 16:30 18:00, Room: 252B Chairpersons: R. Virmani, W. Wijns Panellists: B. Ratner, A. Finn, T. Palmerini, J. Diaz Biomaterials in blood contact applications B. Ratner Pre-clinical evidence on DES performance A. Finn Clinical evidence on DES performance T. Palmerini Case presentation J. Diaz ABBOTT & SIEMENS HEALTHINEERS SPONSORED TOOLS AND TECHNIQUES SESSION HOW TO OPTIMISE PCI WITH ADVANCED IMAGING TECHNOLOGIES: BENEFITS OF THE COMBINED USE OF OCT AND FLUORO REAL-TIME STENT ENHANCEMENT 16:30 18:00, Room: Theatre Bleu Chairpersons: A. Baumbach, N. Meneveau Panellists: F. Burzotta, N. Gonzalo Complex lesions: which PCI approach according to guidelines? N. Gonzalo The added value of OCT and real-time stent enhancement in the decision-making process A. Baumbach LIVE demonstration from Swiss Cardiovascular Centre, Bern University Hospital Bern, Switzerland PCI in bifurcations: a glimpse into the future of OCT-guided PCI F. Burzotta SYMPOSIUM LAA OCCLUSION THERAPY IN THE REAL WORLD 16:30 17:30, Room: 251 Chairpersons: H. Sievert, G. Tarantini Panellists: D. Hildick-Smith, J.E. Nielsen-Kudsk, G. Montalescot Recent published data on outcomes and procedure for LAA occlusion D. Hildick-Smith ICE as imaging modality for LAA device implant; toy or tool? J.E. Nielsen-Kudsk Building the referral network; it is not as simple as it sounds G. Montalescot

Thursday 18 th May TOOLS AND TECHNIQUES SESSION APPLICATION OF THE ILUMIEN III PCI OPTIMISATION CRITERIA IN THE REAL WORLD 12:30 14:00, Room: Theatre Havane Chairpersons: T. Johnson, L. Räber Panellists: Z. Ali, U. Landmesser ILUMIEN III: from clinical outcomes to new optimisation criteria Z. Ali LIVE demonstration from Cardiovascular Research Center OLV Aalst Aalst, Belgium Does ILUMIEN III change my practice? T. Johnson SYMPOSIUM BVS: REVIEWING THE EVIDENCE AND DISTILLING THE LEARNINGS 12:30 14:00, Room: Maillot Chairpersons: W. Wijns, C.K. Naber, G.W. Stone Panellists: A. Al Nooryani, A. Seth, A. Latib BVS review and analyse the data from randomised studies G.W. Stone BVS real-world evidence what did we learn? C.K. Naber 2017: rationale for choosing BVS for my patients A. Latib ILUMIEN IV: what is the future of OCT guidance in PCI? U. Landmesser

Abbott Training Village Join us to gain extensive expertise and experience of working with our Abbott technologies. We offer hands-on exercises and practical insight into how, and when, to use the broad range of advanced technologies offered by Abbott to optimise patient outcomes in your daily practice. A wide range of sessions on offer: Fellow sessions in support of the Fellow Program OCT sessions to optimise PCI in daily practice FFR sessions: indications and standardised technique for coronary physiology assessment Structural Heart product sessions including: Vessel Closure, MitraClip, LAAO and TAVI Vascular product sessions including: Guidewires, drug-eluting stents and bioresorbable scaffolds To find out more information on our training sessions please visit: www.abbottateuropcr.com To sign up for these sessions, please contact your Abbott sales representative or visit us at the Training Village during EuroPCR.

PALAIS DES CONGRÈS DE PARIS 2, Place de la Porte Maillot 75017 Paris France Tel. +33 (0) 1 40 68 00 05 / 22 22 For any questions please contact your local representative. VISIT OUR BOOTH, INNOVATION PAVILION AND TRAINING VILLAGE TO DISCOVER OUR TECHNOLOGY AND ACTIVITIES We look forward to seeing you in Paris, May 16 th 19 th 2017 OPENING HOURS Course Exhibition Registration Sun 14 th May 14:00 18:00 Mon 15 th May 07:00 19:00 Tue 16 th May 10:00 18:45 08:30 18:45 07:00 18:45 Wed 17 th May 08:30 18:00 07:30 18:00 07:30 18:30 Thu 18 th May 08:00 18:00 07:30 18:00 07:30 18:00 Fri 19 th May 08:30 13:00 07:30 13:00 07:30 13:00 All products herein are trademarks of the Abbott Group of Companies. Photo(s) on file at Abbott Vascular. All drawings are artist s representations only and should not be considered as an engineering drawing or photograph. Products intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use provided inside the product carton (when available) or at eifu.abbottvascular.com for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. MitraClip is subject to prior training requirement as per the Instructions for Use. Information contained herein is for distribution for Europe, Middle East and Africa only, and not intended for physicians from France. Please check the regulatory status of the device before distribution in areas where CE marking is not the regulation in force. For more information, visit our website at abbottateuropcr.com 2017 Abbott. All rights reserved. 11-EH-1-6699-01 03-2017